Lucintel Forecasts Biopharmaceutical Contract Manufacturing Market to Grow at a CAGR of 7%-9%

According to the recent study the biopharmaceutical contract manufacturing market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by increasing demand for biopharmaceuticals, cost and time saving benefits offered by contract services, and rising pharmaceutical industries leading to outsourcing services.

Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in biopharmaceutical contract manufacturing market by product (biologics (monoclonal antibodies (MAbs), recombinant proteins, and vaccines), antisense, RNAi, & molecular therapy, and biosimilars), service (process development (downstream and upstream), fill & finish operations, analytical & QC studies, and packaging), therapeutic area (autoimmune disease, oncology, metabolic disease, ophthalmology, cardiovascular disease, infectious disease, neurology, respiratory disorder, and others), source (mammalian and non-mammalian), application (commercial and clinical), and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/biopharmaceutical-contract-manufacturing-market.aspx

“Biologics market is expected to remain the largest segment during the forecast period.”       

Based on product, the biopharmaceutical contract manufacturing market is segmented into biologics (monoclonal antibodies (MAbs), recombinant proteins, and vaccines), antisense, RNAi, & molecular therapy, and biosimilars. Lucintel forecasts that the biologics market is expected to remain the largest segment during the forecast period due to increasing stringent regulatory framework related to biologics which is forcing pharmaceutical companies to adopt for contract manufacturing services.

“Within the biopharmaceutical contract manufacturing market, the process development segment is expected to remain the largest service.”    

Based on service, the process development segment is expected to witness the largest segment over the forecast period due to the presence of advanced technologies and high capital expenditure in small and medium pharmaceutical companies that are opting for contract manufacturing.

“North America will dominate the biopharmaceutical contract manufacturing market in near future.”

North America is expected to be the largest region over the forecast period due to increasing research activities related to biopharmaceutical, rising demand for biologics, and presence of major pharmaceutical companies in the region.

Download Brochure of this report by clicking on https://www.lucintel.com/biopharmaceutical-contract-manufacturing-market.aspx

Major players of biopharmaceutical contract manufacturing market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Lonza, Inno Biologics, Rentschler Biotechnologie, JRS Pharma, AGC Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies, Toyobo, Samsung BioLogics, and Thermo Fisher Scientific are among the major biopharmaceutical contract manufacturing providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/biopharmaceutical-contract-manufacturing-market.aspx or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Minimally Invasive Surgical Instrument Market:

For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

 

Endoscopy Equipment Market:

For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

 

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx